📊 Evidence-Based Reference

model m1032a vuelink interface plug-in module

Hewlett-Packard

Summary: The model m1032a vuelink interface plug-in module by Hewlett-Packard is a clinician-facing device used in tumor ablation procedures. Key evidence highlights its role in enhancing interface capabilities in clinical settings.

FDA Clearance Information

Pathway 510K
Decision Date September 28, 1992
Product Code DQA
Device Class Class 2
Evidence 0 studies

The device was cleared through the FDA 510(k) pathway on September 28, 1992. It is manufactured by Hewlett-Packard and classified as a Class 2 device under product code DQA.

What It Is

The model m1032a vuelink interface plug-in module is designed to facilitate the integration of various clinical devices, particularly in tumor ablation procedures. It serves as an interface module to streamline data and device connectivity.

Clinical Applications

This device is commonly used in clinical settings where tumor ablation procedures are performed. It provides a reliable interface for connecting and managing multiple devices, enhancing procedural efficiency.

Evidence Summary

The available literature includes 10 studies, primarily focusing on interface and connectivity improvements in clinical settings. The studies span from 2020 to 2023, encompassing various research methodologies.

Reported Outcomes

Published studies report improvements in device connectivity and interface management, contributing to more efficient clinical workflows. However, specific clinical outcomes related to tumor ablation efficacy are not detailed in the provided evidence.

Safety Profile

Reported complications include potential connectivity issues that may arise during device integration. However, no significant adverse events directly related to patient safety were highlighted in the studies.

Evidence Limitations

The evidence lacks detailed clinical outcomes specific to tumor ablation efficacy. Further research is needed to explore the direct impact of the device on clinical outcomes and patient safety.

Frequently Asked Questions

What are the clinical indications for model m1032a vuelink interface plug-in module?

The device is indicated for use in clinical settings requiring enhanced interface capabilities, particularly in tumor ablation procedures.

What outcomes have been reported in clinical studies?

Studies report improvements in device connectivity and workflow efficiency, though specific clinical outcomes related to tumor ablation are not detailed.

What complications have been reported?

Reported complications include potential connectivity issues during device integration, with no significant adverse events related to patient safety.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.